1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus

被引:5
|
作者
Gupta, Paridhi [1 ]
Sharma, Anuj [1 ]
Spurgers, Kevin B. [2 ]
Bakken, Russell R. [2 ]
Eccleston, Lori T. [2 ]
Cohen, Jeffrey W. [2 ]
Honnold, Shelley P. [2 ]
Glass, Pamela J. [2 ]
Maheshwari, Radha K. [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA
[2] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA
关键词
Venezuelan equine encephalitis; Vaccine; Inactivated; Iodonaphthyl azide; Aerosol challenge; Protection; STRUCTURAL INTEGRITY; NONHUMAN-PRIMATES; PRESERVATION; VACCINES; INFECTION; RESPONSES; ANTIBODY; VEEV;
D O I
10.1016/j.vaccine.2016.04.049
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Venezuelan equine encephalitis virus (VEEV) is a New World alphavirus. VEEV is highly infectious in aerosolized form and has been identified as a bio-terrorism agent. There is no licensed vaccine for prophylaxis against VEEV. The current IND vaccine is poorly immunogenic and does not protect against an aerosol challenge with virulent VEEV. We have previously shown that VEEV inactivated by 1,5-iodonaphthyl azide (INA) protects against footpad challenge with virulent VEEV. In this study, we inactivated an attenuated strain of VEEV, V3526, with INA and evaluated its protective efficacy against aerosol challenge with wild type VEEV. We demonstrated that among three routes of immunization, intramuscular immunization with INA-inactivate V3526 (INA-iV3526) provided complete protection against aerosol challenge with virulent VEEV. Our data suggests that INA-iV3526 can be explored further for development as an effective vaccine candidate against aerosol challenge of virulent VEEV. (C) 2016 Published by Elsevier Ltd.
引用
收藏
页码:2762 / 2765
页数:4
相关论文
共 27 条
  • [1] Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus
    Martin, Shannon S.
    Bakken, Russell R.
    Lind, Cathleen M.
    Garcia, Patricia
    Jenkins, Erin
    Glass, Pamela J.
    Parker, Michael D.
    Hart, Mary Kate
    Fine, Donald L.
    VACCINE, 2010, 28 (18) : 3143 - 3151
  • [2] Toxicity assessment of Venezuelan Equine Encephalitis virus vaccine candidate strain v3526
    Rao, V
    Hinz, ME
    Roberts, BA
    Fine, D
    VACCINE, 2006, 24 (10) : 1710 - 1715
  • [3] Venezuelan equine encephalitis virus candidate vaccine (V3526) protects hamsters from challenge by both mosquito bite or intraperitoneal injection
    Turell, Michael J.
    Parker, Michael D.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 197 - 197
  • [4] Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses
    Fine, Donald L.
    Roberts, Brian A.
    Teehee, Max L.
    Terpening, Sara J.
    Kelly, Cindy L. H.
    Raetz, Janae L.
    Baker, Dale C.
    Powers, Ann M.
    Bowen, Richard A.
    VACCINE, 2007, 25 (10) : 1868 - 1876
  • [5] Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection
    Turell, Michael J.
    Parker, Michael D.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 78 (02): : 328 - 332
  • [6] Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB
    Martin, Shannon S.
    Bakken, Russell R.
    Lind, Cathleen M.
    Garcia, Patricia
    Jenkins, Erin
    Glass, Pamela J.
    Parker, Michael D.
    Hart, Mary Kate
    Fine, Donald L.
    VACCINE, 2010, 28 (04) : 1031 - 1040
  • [7] Environmental hazard assessment of Venezuelan equine encephalitis virus vaccine candidate strain V3526
    Rao, V
    Hinz, ME
    Roberts, BA
    Fine, D
    VACCINE, 2004, 22 (20) : 2667 - 2673
  • [8] Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate
    Hart, MK
    Caswell-Stephan, K
    Bakken, R
    Tammariello, R
    Pratt, W
    Davis, N
    Johnston, RE
    Smith, J
    Steele, K
    VACCINE, 2000, 18 (26) : 3067 - 3075
  • [9] Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge
    Kafai, Natasha M.
    Williamson, Lauren E.
    Binshtein, Elad
    Sukupolvi-Petty, Soila
    Gardner, Christina L.
    Liu, Jaclyn
    Mackin, Samantha
    Kim, Arthur S.
    Kose, Nurgun
    Carnahan, Robert H.
    Jung, Ana
    Droit, Lindsay
    Reed, Douglas S.
    Handley, Scott A.
    Klimstra, William B.
    Crowe, James E.
    Diamond, Michael S.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 219 (04):
  • [10] PROTECTIVE EFFICACIES OF LIVE ATTENUATED AND FORMALDEHYDE-INACTIVATED VENEZUELAN EQUINE ENCEPHALITIS-VIRUS VACCINES AGAINST AEROSOL CHALLENGE IN HAMSTERS
    JAHRLING, PB
    STEPHENSON, EH
    JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (03) : 429 - 431